Trials
Search / Trial NCT06416878

Brief ES for Recovery of Autonomic Function in CES

Launched by UNIVERSITY OF LIVERPOOL · May 15, 2024

Trial Information

Current as of February 18, 2025

Recruiting

Keywords

Cauda Equina Syndrome Electrical Stimulation Spinal Cord Stimulator Recovery Of Autonomic Function Axonal Regeneration

ClinConnect Summary

The BESCES trial is studying a new approach to help patients with cauda equina syndrome (CES), a condition that can cause problems with bladder, bowel, or sexual function due to nerve compression in the lower back. In this study, researchers are looking at whether a brief electrical stimulation applied during surgery can help improve nerve function after the pressure is relieved. If patients don’t regain their functions after surgery, they may receive this electrical stimulation afterward to see if it can help them urinate or allow for catheter removal.

To participate in this trial, individuals must be over 18 and experiencing bladder, bowel, or sexual issues due to sudden nerve problems from a slipped disc. The study is currently recruiting participants, and it does not matter if they are male or female. Those who join can expect to have a brief electrical stimulation device used during and possibly after their surgery, which could offer a new way to help recover nerve function. It’s important to note that some people may not be eligible, including those with certain medical conditions or previous surgeries that could complicate the procedure.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \>18.
  • Cauda equina syndrome with bladder, bowel or sexual dysfunction (CES-I or CES-R) secondary to acute lumbar disc prolapse.
  • Selected for emergency surgery.
  • Exclusion Criteria:
  • No bladder, bowel or sexual dysfunction (Only bilateral radicular symptoms).
  • Previous spinal surgery with risk of adhesions.
  • Multilevel degeneration with inadequate safe space to pass epidural electrode.
  • Pre-existent bladder, bowel or sexual dysfunction.
  • History of peripheral neuropathy.
  • Contraindications to neurostimulation (e.g. pacemaker, immune deficiency, uncontrolled diabetes, sepsis, active pressure sore, spinal cord stimulator in situ).
  • Intraoperative CSF leak.

Trial Officials

Andrew Marshall, PhD

Study Chair

University of Liverpool

About University Of Liverpool

The University of Liverpool is a prestigious academic institution renowned for its commitment to advancing healthcare and medical research through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various scientific fields to address critical health challenges. By fostering an environment of rigorous research, the University of Liverpool aims to translate findings into practical applications that improve patient outcomes and contribute to the global body of medical knowledge. Through its dedicated clinical trial initiatives, the university strives to uphold the highest ethical standards while promoting scientific excellence and community engagement.

Locations

Liverpool, Merseyside, United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0